AstraZeneca’s Breast Cancer Drug Fails to Earn Backing of FDA Advisory Committee
The FDA’s advisory committee voted against recommending AstraZeneca’s oral SERD camizestrant for HR⁺/HER2‑ metastatic breast cancer patients with an ESR1 mutation, citing concerns over the Phase 3 SERENA‑6 trial design. The study switched patients to camizestrant at the point of mutation testing rather than at radiographic progression, an early intervention lacking overall survival data. While the trial demonstrated a 56% reduction in disease progression or death, the panel argued that the evidence does not yet justify a paradigm shift. AstraZeneca continues to develop camizestrant in other breast‑cancer settings, but the setback may delay broader regulatory approval.
Lilly's Double-Beat Widens the GLP-1 Gap—And a New Pill Could Make It Permanent
Eli Lilly posted a strong Q1 2026, with revenue up 56% YoY to almost $20 billion, driven by $12.8 billion in GLP‑1 sales from Mounjaro and Zepbound. The FDA also approved Foundayo, the first oral GLP‑1 agonist for obesity that can be taken without...
BIO on the American Road Tours Gene Therapy Hub in Ohio
BIO President John F. Crowley toured Ohio on April 28, spotlighting the state’s emerging gene‑therapy hub. Researchers at Nationwide Children’s Hospital have delivered two of the FDA’s first eight approved gene therapies for Duchenne muscular dystrophy and spinal muscular atrophy type 1....
The Quiet Revolution in Battery Technology That’s Powering Your Next Artificial Heart
Inspired Energy is spearheading a quiet revolution with smart lithium‑ion battery packs that embed microcontrollers for real‑time monitoring of charge, temperature, and health. The technology targets medical and robotics OEMs, offering FDA‑compliant safety, higher energy density, and dynamic power delivery...
Mobile PET Scan Provider to Pay $8.33 Million to Resolve Allegations of False Claims Act Violations Based on Unlawful Kickbacks...
Modern Nuclear Inc., a mobile PET‑scan provider, agreed to pay $8,334,350.71 to resolve False Claims Act allegations that it offered cardiologists above‑market fees for patient referrals, violating the Anti‑Kickback Statute. The settlement, based on the company’s ability to pay, also...
Oklahoma City Woman Sentenced to Federal Prison for $1.1 Million Health Care Fraud Scheme
Natasha Allmon, a 49‑year‑old Oklahoma City resident, received a 20‑month federal prison sentence for submitting fraudulent behavioral health claims to Blue Cross Blue Shield. Between January 2021 and December 2023 she filed roughly $1.4 million in false claims, pocketing about $1.1 million in reimbursements....
Every Mental Health Journey Begins with Being Seen
Mental Health Awareness Month spotlights SAMHSA’s “See the Person, Support the Journey” campaign, urging compassionate, person‑centered care in crisis settings. The agency cites 61 million U.S. adults experiencing mental illness in 2024, with 15 million facing serious conditions, underscoring persistent treatment gaps....
Seaport, Hemab Price IPOs, While Avalyn Soars in Nasdaq Debut
Three biotech companies priced their initial public offerings between Thursday and Friday, collectively raising more than $850 million. Seaport Therapeutics secured $225 million at $20 per share, while Hemab Therapeutics attracted $210 million at $18 per share. Avalyn Pharma led the pack with...
MDMA-Assisted Therapy for Depression: A Promising but Early First Step
A small open‑label proof‑of‑principle study examined MDMA‑assisted therapy in 12 adults with moderate‑to‑severe major depressive disorder. Participants received two MDMA dosing sessions spaced a month apart together with nine psychotherapy sessions. At two months, 75% of participants achieved remission and...
Cue Biopharma Licenses Ascendant-221 From Ascendant Health Sciences in a ~$691.5M Deal
Cue Biopharma announced an exclusive license with Ascendant Health Sciences for Ascendant-221, an anti‑IgE monoclonal antibody aimed at allergic diseases. The agreement grants Cue worldwide rights, except Greater China, in exchange for a $15 million upfront payment and up to $676.5 million...
Approaches to Reducing Toxicity and Side Effects in Cell and Gene Therapy
Cell and gene therapies are expanding rapidly, with the market projected to exceed $9 billion in 2025 and grow over 15% annually through 2035. Safety remains a hurdle, prompting multiple strategies to curb cytokine release syndrome (CRS) and related toxicities. Companies...
FDA's ODAC Delivers One Loss, One Win for AstraZeneca
The FDA’s Oncologic Drugs Advisory Committee (ODAC) voted 6‑3 against AstraZeneca’s oral SERD camizestrant in combination with CDK‑4/6 inhibitors for first‑line HR‑positive, HER2‑negative breast cancer with ESR1 mutations, citing a lack of overall survival benefit despite a 56% progression‑free survival...
Gene Editing at Scale, Clinic Seeks Generalizable Therapies
Integrated DNA Technologies helped deliver a CRISPR therapy that rescued baby KJ Muldoon from a fatal urea‑cycle disorder, proving gene editing can correct a single disease‑causing mutation. The success highlights the field’s next hurdle: scaling personalized edits for disorders with...
Smarter AAVs Drive Gene Therapy’s Next Chapter
Gene therapy’s growth is hampered by AAV manufacturing bottlenecks, safety concerns, and high costs, prompting a wave of innovations across bioprocessing, analytics, and vector design. Companies like Thermo Fisher, PackGene, Catalent, and Asimov are deploying design‑space modeling, high‑throughput purification, and...
Boehringer Appoints Pharma Veteran for Corporate Affairs Post; BlueRock CSO Heads for the Exit
Boehringer Ingelheim has appointed Christie Bloomquist as senior vice president of corporate affairs for its U.S. human pharmaceuticals division, while also naming her president of the Boehringer Cares Foundation. Bloomquist brings more than two decades of experience in pharma regulatory...
Behavioral Health Is Health Care
Mental Health Awareness Month underscores a surge in demand for behavioral health services across hospitals. Emergency departments, primary care, and pediatric clinics are seeing record numbers of patients in crisis. Health systems are responding by embedding behavioral specialists, expanding tele‑behavioral...
Former Surgeon General Jerome Adams on Trump's New Pick for the Role
Former Surgeon General Jerome Adams evaluated President Trump’s latest Surgeon General nominee, radiologist Nicole Saphier. Adams noted that Saphier meets the basic credential threshold and enjoys a public‑facing platform as a Fox News contributor, but she lacks the traditional public‑health training of...
Martha's Rule Helplines Get More than 1,700 Calls From Worried NHS Staff
More than 1,700 NHS staff in England have used the Martha’s Rule helplines since they launched in September 2024 to flag concerns about patient deterioration. The scheme, created after the tragic death of 13‑year‑old Martha Mills, now operates in 143...
‘There Is an Imbalance of Power’: My Husband Has Cancer. Why Must We Wait Two Hours for a 10-Minute CT...
A patient’s letter to a prominent cancer‑care center highlights chronic, multi‑hour waits for brief CT scans and infusion appointments, a pattern she attributes to systematic overbooking aimed at offsetting 40‑50% no‑show rates. The letter proposes that providers waive fees when...
What to Do After a Serious Birth Injury
A serious birth injury shifts the focus from celebration to urgent medical and legal action. Families are urged to collect comprehensive medical records, staff lists, and detailed timelines immediately, while also tracking the high costs of NICU equipment such as...
Identifying the Ages when Alzheimer’s Biomarkers Sharply Change
A Mayo Clinic Study of Aging analysis identified specific ages when Alzheimer’s disease biomarkers change sharply, using breakpoint regression on plasma proteins, PET imaging, hippocampal volume and cognition across 45‑90‑year‑olds. The most consistent inflection points clustered between 62 and 71...
Humanizing Health Architecture
Renowned architects Renzo Piano, Norman Foster and David Adjaye argue that modern hospitals have sacrificed humanity for efficiency. They champion designs that re‑introduce nature, natural light, and a sense of place, citing Piano’s suspended children’s hospice in Bologna and Foster’s...
ECRI Urges Congress to Strengthen Regulatory Transparency for Digital Health and CDS Tools
ECRI, a nonprofit patient‑safety group, submitted recommendations to the House Energy and Commerce Subcommittee urging stronger regulatory transparency for digital health and clinical decision‑support (CDS) tools. The organization warns that many wellness devices—such as blood‑pressure and glucose monitors—operate without FDA...
How Saudi Arabia Is Developing as a Middle East Hub for Clinical Trials
Saudi Arabia is positioning itself as the Middle East’s primary hub for clinical trials, backed by robust state investment and the Vision 2030 Health Sector Transformation Programme. Healthcare spending is forecast to reach $61.05 million in 2026, while pharmaceutical sales are...
AI Scribes Save Clinicians Time but Fail to Reduce Overtime Work
A multisite JAMA study found AI‑powered scribes trim clinicians' electronic health record (EHR) documentation by about 13 minutes and boost weekly patient visits by roughly half a visit per provider. The time savings translate into an estimated $167 extra monthly...
Transparent Healthcare Prices Won’t Lower Patients’ Costs
Congressional leaders are pushing price‑transparency legislation, including the bipartisan Patients Deserve Price Tags Act and a House bill that would codify hospital price disclosures and require PBM rebate reporting. While the measures aim to make upfront costs visible, experts argue...
Mount Sinai Queens ICU Expansion Groundbreaking Marks Major Critical Care Milestone in Astoria
Mount Sinai Health System broke ground on April 30, 2026, for a new intensive care unit at its Queens campus. The sixth‑floor conversion will add 13 ICU beds, raising total ICU capacity from eight to 21 and increasing certified hospital...
PHA Seeks More Accessible Heart Failure Care Network
The Philippine Heart Association (PHA) launched its Heart Failure Caravan across nine cities, including Cebu, to build a more accessible network for heart‑failure (HF) care. The association highlighted that roughly 10.4% of Filipinos suffer from HF, a figure driven by...
Research Says Do This 2 Weeks Before Surgery To Recover Faster
A recent meta‑analysis of 23 randomized trials involving 2,182 patients found that pre‑surgery conditioning—known as prehabilitation—significantly improves outcomes. Exercise‑ or nutrition‑based programs cut postoperative complications by roughly 48% and can shorten hospital stays by about one day. Programs ranging from...
This Treatment Could Reverse Osteoarthritis Joint Damage With a Single Injection
Researchers at the University of Colorado Boulder have secured a $33.5 million ARPA‑H grant to develop a regenerative osteoarthritis therapy that could reverse joint damage with a single injection. The approach uses a controlled‑release particle system to deliver an approved drug...
5 Questions to Ask Before Choosing an Assisted Living Facility
Choosing an assisted‑living community is a high‑stakes decision that shapes daily life, safety, and long‑term happiness. Prospective residents should probe the exact level of care, from basic assistance to specialized memory‑care programs, and understand how personalized plans evolve. Safety measures—emergency...
MintNeuro and Motif Neurotech Collaborate for Mental Health Therapies
MintNeuro and Motif Neurotech have entered a multi‑year commercial supply agreement to integrate MintNeuro’s low‑power neural interface chips into Motif’s clinical‑stage implant platform. The partnership will support pre‑clinical, early‑clinical and pivotal trials targeting depression, bipolar disorder and treatment‑resistant depression. Motif...
Gavin Newsom, Early Champion of Single-Payer, Moderates in the Face of Fiscal Limits
Governor Gavin Newsom entered office championing a California single‑payer system, but the $500 billion annual cost and lack of federal support forced a pivot to incremental reforms. He expanded Medi‑Cal to cover low‑income immigrants and incarcerated people, launched the CalRx generic‑drug...
Delays in Visa Program Threaten Placement of Hundreds of Doctors in Underserved Areas
The Department of Health and Human Services’ J‑1 visa waiver program has amassed a backlog of hundreds of applications, delaying the transition of foreign‑trained doctors to H‑1B status. Without rapid processing, these physicians must leave the U.S. by July 30,...
What Are the Chances AI Will Give You Accurate Health Advice? 50/50, Says a New Study
Researchers evaluated five leading AI chatbots, including Gemini and ChatGPT, on 50 medical questions across topics such as cancer, vaccines, nutrition, and athletic performance. Expert reviewers found that overall accuracy was roughly 50%, with 49.6% of responses deemed problematic and...
Comparative Assessment of Brassica Nigra Seed and Its Sprout Ethanolic Extracts Against Paracetamol-Induced Hepatotoxicity in Rats: Insight Into Antioxidant and...
Researchers compared ethanolic extracts of Brassica nigra (black mustard) seeds and sprouts for protecting rat livers against a high‑dose paracetamol challenge. Rats received 500 mg/kg body weight of each extract for 21 days, with silymarin (100 mg/kg) as a reference drug. Both extracts...
STAT+: Her Daughter Mila Got a Bespoke Medicine. Now She’s Starting a New Biotech to Make More
Julia Vitarello, whose eight‑year‑old daughter Mila was treated with a tailor‑made gene therapy, announced she is launching a new biotech to scale individualized medicines. Her previous company, EveryONE Medicines, folded after FDA guidance on custom therapies proved insufficient for investors....
PwC Drops Weight Loss Drugs From Employee Benefits in the US
PwC’s U.S. unit will stop covering GLP‑1 weight‑loss drugs for employees without diabetes, citing rapidly rising drug costs. Effective July, only staff with a diabetes diagnosis will remain eligible for medications such as Ozempic and Mounjaro. The drugs cost roughly...
Teen Talent Vows to Return From Brain Hemorrhage and Paralysis After Roubaix Crash
Teen cyclist Kamilla Aasebø, 19, survived a devastating Paris‑Roubaix Femmes crash that left her with a brain hemorrhage, and fractures to her elbow and jaw. After ten days of emergency care in Lille, she returned to Oslo for rehabilitation, focusing...
State Tele-Buprenorphine Prescribing Policies by Medical Professional Type
A RAND‑led legal mapping of all 50 states and D.C. reveals stark differences in Medicaid policies governing fully virtual buprenorphine prescribing for opioid use disorder. While 32 states permit physicians, nurse practitioners and physician assistants to prescribe via telemedicine, 12...
Opinion: California Must Defend Nurses or Patients Will Pay the Price
The Trump administration’s 2025 budget bill (H.R. 1) caps federal student loans for graduate programs and strips nursing of its professional‑degree status, jeopardizing access to advanced nursing education. The caps force students onto costly private loans, risk closing nursing schools, and...
UK Biobank Has My Data, but I’m Not Worried. I Know the Benefits Are Too Great to Consider Pulling Out...
The UK Biobank, a half‑million‑person health study, briefly listed anonymised data on China’s Alibaba platform, prompting headlines about a data breach. Officials clarified that no personal identifiers were included and the listings were swiftly removed, resulting in only about 50...
NHS England Seeks Market Engagement on End-to-End Diagnostic Testing Pathways for NHS Online
NHS England has issued a preliminary market engagement notice to assess the feasibility of end‑to‑end diagnostic testing pathways for its upcoming NHS Online virtual hospital service. The engagement will inform a future commercial contract valued at roughly £160,000 (about $200,000)...
SANBS Announced as Gold Sponsor for #HISA2026 at Indaba Hotel Conference Centre
South African National Blood Service (SANBS) has been announced as a Gold Sponsor for the Healthcare Innovation Summit Africa 2026, which will be held on 27‑28 May at Johannesburg’s Indaba Hotel Conference Centre. HISA 2026, now in its tenth edition, gathers...
Digital Tool to Analyse Maternity Data
The NHS is launching the Maternal Outcomes Signal System (MOSS), a digital platform that rapidly analyses routine maternity data to highlight emerging safety concerns. The tool will generate six‑month reports, prompting trusts to act on identified risks. The government has...
Scientists Build Drug-Carrying DNA Robots to Target Diseases
Scientists have engineered microscopic DNA robots that can carry therapeutic payloads and seek out viruses, acting as nano‑surgeons within the bloodstream. By applying origami‑inspired rigid joints and flexible components, the robots achieve nanometer‑scale precision. Movement is programmed through DNA strand...
Nuclear Verdicts and Rising Claims Costs: How Hospitals Can Navigate an Increasingly Difficult Liability Market
The U.S. hospital liability market is entering a hard‑market phase as nuclear verdicts—cases exceeding $10 million—have surged from 48 in 2022 to 55 in 2025, with total damages climbing from $1.3 billion to $2.5 billion. Insurers cite rising claim frequency and severity, especially...
6 Strategies to Help Meet HR1 Eligibility and Enrollment Requirements
The One Big Beautiful Bill (HR1) overhauls Medicaid and SNAP eligibility, with compliance deadlines of Dec 31 2026. State agencies must modernize their enrollment systems to avoid costly delays. Mike Hall outlines six strategies—redesigning community‑engagement workflows, launching early data‑driven outreach, adopting flexible...
How Long Should You Be on a GLP-1?
Semaglutide and other GLP‑1 agonists trigger appetite suppression and noticeable weight loss within the first month, with most patients shedding 15‑25% of body weight after a year. Clinical trials show that continuous use for four years markedly reduces heart attacks,...
How To Follow a Healthy Diet With LEMS
Living with Lambert‑Eaton Myasthenic Syndrome (LEMS) brings muscle weakness, fatigue, and digestive challenges that can undermine daily function. Neurologist Dr. Georgette Dib emphasizes that while diet won’t cure LEMS, a balanced, Mediterranean‑inspired eating plan can bolster muscle strength, energy, gut...